Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

GEMZ

Name: The Phase III GEMZ trial of fenfluramine in CDKL5 deficiency disorder
Uploaded: 2026-09-28T00:00:00Z
Duration: 2 min 10 s

Sorry, no posts matched your criteria.

GEMZ

Cookie settings